News EyePoint’s Late-stage Eye Drug Trials to Continue After Safety Panel Review by Medscape • 2026/05/14 • 0 Comments EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug Duravyu and recommended the... Reuters Health Information